The European Union (EU) has granted CE mark to Boston Scientific's deep brain stimulator to treat Parkinson's disease.
The Vercise deep brain stimulator, which includes multiple independent current control, uses electrical signals to stimulate specific areas of the brain.
By controlling current at each individual contact on the lead, the stimulator also minimizes the side effects of stimulation.
University Clinic Wurzburg neurology department director Jens Volkmann said the clinic believes that the Vercise stimulator represents advancement in DBS technology through flexible and programming options.
"We believe the system gives neurologists the ability to precisely target stimulation based on patient needs," Volkmann added.
University Clinic Wurzburg functional neurosurgery head Cordula Matthies said, "I look forward to seeing a positive impact in patients' quality of life."
